Skip to main content
. 2018 Dec 4;9:740. doi: 10.3389/fendo.2018.00740

Table 2.

NETest outcome in each group using the cut off of 14%.

NET Controls Total
NETest positive 130 50 180
NETest negative 10 63 73
Total 140 113 253

NET, neuroendocrine tumor.